Horizons Ventures

Cannabinoid-focused biotechnology company Demetrix announced Thursday it secured $50 million in a Series A funding round led by Tuatara Capital. Another investor is Horizons Ventures, which previously led Demetrix's $11 million Series Seed round. Demetrix aims to develop a technology that would...